APA (7th ed.) Citation

M, A., F, S., LL, Z., FO, A., NR, W., A, Z., . . . A, S. (2023). Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. The oncologist, 28(11), e1065. https://doi.org/10.1093/oncolo/oyad118

Chicago Style (17th ed.) Citation

M, Altan, et al. "Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience." The Oncologist 28, no. 11 (2023): e1065. https://doi.org/10.1093/oncolo/oyad118.

MLA (9th ed.) Citation

M, Altan, et al. "Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience." The Oncologist, vol. 28, no. 11, 2023, p. e1065, https://doi.org/10.1093/oncolo/oyad118.